Last update 01 Nov 2024
[89Zr]Zr-Df-Crefmirlimab
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC) |
Synonyms- |
Target |
Mechanism CD8 inhibitors(Cluster of differentiation 8 inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Boost your research with our XDC technology data.
login
or
Related
3
Clinical Trials associated with [89Zr]Zr-Df-CrefmirlimabCD8 T cell imaging by positron emission tomography with 89Zr-Df-crefmirlimab in giant cell arteritis and rheumatoid arthritis: a pilot study
A Phase II, Open Label, Multi-center Study of 89Zr-DF-Crefmirlimab for CD8 Positron Emission Tomography in Patients With Locally Advanced or Metastatic Solid Tumours
Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Response in Non-Small Cell Lung Cancer
100 Clinical Results associated with [89Zr]Zr-Df-Crefmirlimab
Login to view more data
100 Translational Medicine associated with [89Zr]Zr-Df-Crefmirlimab
Login to view more data
100 Patents (Medical) associated with [89Zr]Zr-Df-Crefmirlimab
Login to view more data
100 Deals associated with [89Zr]Zr-Df-Crefmirlimab
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | ES | 01 Aug 2024 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | NL | 01 Aug 2024 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | GB | 01 Aug 2024 | |
| Metastatic Solid Tumor | Phase 2 | ES | 01 Aug 2024 | |
| Metastatic Solid Tumor | Phase 2 | NL | 01 Aug 2024 | |
| Metastatic Solid Tumor | Phase 2 | GB | 01 Aug 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free